Since the acridone derivative A22 could up-regulate the expression of BCL-2 and alleviate the hepatic apoptosis-associated pathological features of NAFLD/NASH, in the present study, we further examined its anti-apoptotic effect on the FA-induced kidney cell apoptosis model. This evidence concerns the gene BCL2 and metabolic dysfunction-associated steatotic liver disease.